Award
National Cancer Institute 5R01CA289447-02
Reducing Off-Target Accumulation of Chemotherapeutic Nanomedicines
Recipient
Not specified
Award Amount
$500,290.00
Ceiling
$500,290.00
Awarded
March 25, 2026
Identifier
5R01CA289447-02
Award for research on reducing off-target accumulation of chemotherapeutic nanomedicines to improve cancer treatment efficacy and reduce toxicity.
Description
This project involves investigating a novel approach to reduce drug accumulation in healthy tissues during cancer chemotherapy, utilizing immune response modulation with cytokines such as IFN-λ to improve efficacy and reduce toxicity.